Clinical Characteristics, Recurrences, and Complications in the Mexican Pediatric Patients with Vogt-Koyanagi-Harada Disease
Related Experiment Video
Updated: May 9, 2025

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Luz Elena Concha-Del-Rio1, Diego Ivan Cervera-Ruiz2, Ronald Rivera-Sempértegui3
1Inflammatory Eye Disease Clinic, Asociación para Evitar la Ceguera en México, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Insights
Vogt-Koyanagi-Harada (VKH) disease in Mexican children presents challenges due to its aggressive nature. Early diagnosis and combined steroid and immunomodulatory treatment are crucial for better visual outcomes.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Vogt-Koyanagi-Harada (VKH) disease is a rare, systemic autoimmune disorder affecting the eyes, central nervous system, and skin.
- Pediatric VKH disease can have a significant impact on vision and requires careful management.
Purpose of the Study:
- To analyze the clinical characteristics, recurrence rates, and complications of VKH disease in Mexican pediatric patients.
- To evaluate the effectiveness of current treatment strategies in this population.
Main Methods:
- A retrospective review of pediatric patients (≤16 years) diagnosed with VKH disease between January 1988 and February 2023.
- Data collected included clinical findings, treatment approaches, recurrences, complications, and visual acuity outcomes.
Main Results:
- Thirty-one pediatric patients (62 eyes) were analyzed, with a mean age of 12.06 years.
- Initial visual acuity improved significantly after treatment (p=0.001), but 41.93% experienced recurrences.
- Common findings included anterior chamber inflammation (70%) and serous retinal detachment (72%). Frequent complications were sunset-glow fundus (74.19%) and glaucoma (27.41%).
Conclusions:
- Pediatric VKH disease in Mexico is challenging to manage due to its aggressive course.
- Timely diagnosis and combined systemic steroid and immunomodulatory therapy are essential for reducing recurrences and complications, leading to improved visual prognosis.
Purpose:
To analyze the clinical characteristics, number of recurrences, and complications in the Mexican pediatric patients with Vogt-Koyanagi-Harada (VKH) disease.
Methods:
A retrospective review of pediatric patients aged 16 years and under, diagnosed with VKH, was conducted from January 1988 to February 2023 at Asociación para Evitar la Ceguera en México I.A.P.
Results:
Thirty-one patients (n = 62 eyes), with a diagnosis of VKH were identified, with a mean age of 12.06 ± 3.57 years. Follow-up was 7.22 ± 6.85 years. At initial presentation, the best-corrected visual acuity (BCVA) was 1.31 ± 0.94 LogMAR (Snellen 20/400) and final 0.5 ± 0.93 LogMAR (Snellen 20/60) (p = 0.001). The most common clinical findings in the uveitic stage were anterior chamber inflammation (70%) and serous retinal detachment (72%). The treatment approach involved a combination of oral steroids, intravenous steroids, and immunomodulatory agents. Despite the initial visual impairment, most patients achieved disease remission. However, 41.93% of the patients experienced at least one recurrence during follow-up. The most frequent complications were sunset-glow fundus 74.19% (n = 46 eyes), and glaucoma 27.41% (n = 17 eyes).
Conclusion:
VKH disease in the Mexican pediatric patients has proved to be a challenge in management due to its aggressive course. Timely diagnosis and treatment with steroid therapy associated with a systemic immunomodulatory are essential to reduce recurrences, and complications and thus have a better visual prognosis.
More Related Videos
12:58Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...